Elanco Animal Health's Q1 Adjusted Earnings Rise, Revenue Falls; Raises 2025 Revenue Guidance

MT Newswires Live

May 07

Elanco Animal Health (ELAN) reported Q1 adjusted earnings Wednesday of $0.37 per diluted share, up from $0.34 a year earlier. Analysts polled by FactSet expected $0.31.

Revenue for the quarter ended March 31 was $1.19 billion compared with $1.21 billion a year earlier. Analysts expected $1.17 billion.

Shares of the company rose 3.5% in recent premarket activity as Elanco increased its annual revenue guidance to a range of $4.51 billion to $4.58 billion from the prior view of $4.45 billion to $4.51 billion. Analysts polled by FactSet expect $4.48 billion. The company held its 2025 adjusted earnings guidance of $0.80 to $0.86 per share.

For Q2, the company expects adjusted EPS of $0.17 to $0.21 and revenue of $1.18 billion to $1.20 billion. Analysts surveyed by FactSet expect adjusted earnings of $0.25 per share on revenue of $1.17 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2533988334"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533988334\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533988334?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-07 18:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533988334","market":"fut","top_or_hot":-1,"title":"Elanco Animal Health's Q1 Adjusted Earnings Rise, Revenue Falls; Raises 2025 Revenue Guidance","media":"MT Newswires Live","content":"<html><body><p> Elanco Animal Health (ELAN) reported Q1 adjusted earnings Wednesday of $0.37 per diluted share, up from $0.34 a year earlier. Analysts polled by FactSet expected $0.31.</p><p>Revenue for the quarter ended March 31 was $1.19 billion compared with $1.21 billion a year earlier. Analysts expected $1.17 billion.</p><p>Shares of the company rose 3.5% in recent premarket activity as Elanco increased its annual revenue guidance to a range of $4.51 billion to $4.58 billion from the prior view of $4.45 billion to $4.51 billion. Analysts polled by FactSet expect $4.48 billion. The company held its 2025 adjusted earnings guidance of $0.80 to $0.86 per share.</p><p>For Q2, the company expects adjusted EPS of $0.17 to $0.21 and revenue of $1.18 billion to $1.20 billion. Analysts surveyed by FactSet expect adjusted earnings of $0.25 per share on revenue of $1.17 billion.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elanco Animal Health's Q1 Adjusted Earnings Rise, Revenue Falls; Raises 2025 Revenue Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElanco Animal Health's Q1 Adjusted Earnings Rise, Revenue Falls; Raises 2025 Revenue Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-07 18:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Elanco Animal Health (ELAN) reported Q1 adjusted earnings Wednesday of $0.37 per diluted share, up from $0.34 a year earlier. Analysts polled by FactSet expected $0.31.</p><p>Revenue for the quarter ended March 31 was $1.19 billion compared with $1.21 billion a year earlier. Analysts expected $1.17 billion.</p><p>Shares of the company rose 3.5% in recent premarket activity as Elanco increased its annual revenue guidance to a range of $4.51 billion to $4.58 billion from the prior view of $4.45 billion to $4.51 billion. Analysts polled by FactSet expect $4.48 billion. The company held its 2025 adjusted earnings guidance of $0.80 to $0.86 per share.</p><p>For Q2, the company expects adjusted EPS of $0.17 to $0.21 and revenue of $1.18 billion to $1.20 billion. Analysts surveyed by FactSet expect adjusted earnings of $0.25 per share on revenue of $1.17 billion.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELAN","symbol_name":"Elanco Animal Health Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2533988334","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533988334","pubTimestamp":1746615212,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Elanco Animal Health  reported Q1 adjusted earnings Wednesday of $0.37 per diluted share, up from $0.34 a year earlier. Analysts polled by FactSet expected $0.31.Revenue for the quarter ended March 31 was $1.19 billion compared with $1.21 billion a year earlier. Analysts expected $1.17 billion.Shares of the company rose 3.5% in recent premarket activity as Elanco increased its annual revenue guidance to a range of $4.51 billion to $4.58 billion from the prior view of $4.45 billion to $4.51 billion. Analysts polled by FactSet expect $4.48 billion. The company held its 2025 adjusted earnings guidance of $0.80 to $0.86 per share.For Q2, the company expects adjusted EPS of $0.17 to $0.21 and revenue of $1.18 billion to $1.20 billion. Analysts surveyed by FactSet expect adjusted earnings of $0.25 per share on revenue of $1.17 billion.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ELAN":"Elanco Animal Health Inc"},"translate_title":"Elanco Animal Health第一季度调整后盈利增长，收入下降；提高2025年收入指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELAN":0.9},"content_text":"Elanco Animal Health (ELAN) reported Q1 adjusted earnings Wednesday of $0.37 per diluted share, up from $0.34 a year earlier. Analysts polled by FactSet expected $0.31.Revenue for the quarter ended March 31 was $1.19 billion compared with $1.21 billion a year earlier. Analysts expected $1.17 billion.Shares of the company rose 3.5% in recent premarket activity as Elanco increased its annual revenue guidance to a range of $4.51 billion to $4.58 billion from the prior view of $4.45 billion to $4.51 billion. Analysts polled by FactSet expect $4.48 billion. The company held its 2025 adjusted earnings guidance of $0.80 to $0.86 per share.For Q2, the company expects adjusted EPS of $0.17 to $0.21 and revenue of $1.18 billion to $1.20 billion. Analysts surveyed by FactSet expect adjusted earnings of $0.25 per share on revenue of $1.17 billion.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}